Enloplatin
Alternative Names: CL 287110Latest Information Update: 05 Oct 2011
At a glance
- Originator Wyeth
- Class Antineoplastics; Platinum complexes; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 18 Oct 2000 No-Development-Reported for Leukaemia (Unknown route)
- 18 Oct 2000 No-Development-Reported for Lymphoma (Unknown route)
- 18 Oct 2000 No-Development-Reported for Ovarian cancer in Belgium (Unknown route)